December 22, 2014 11:48 PM ET

Biotechnology

Company Overview of Apellis Pharmaceuticals, Inc.

Executive Profile

Michael Yeadon Ph.D.

Member of Scientific Advisory Board, Pulmatrix, Inc.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 2 different industries.

See Board Relationships
----

Background

Dr. Michael Yeadon, PhD, served as Consultant Acting Chief Scientific Officer at Apellis Pharmaceuticals, Inc. Dr. Yeadon served as the Vice President and Chief Scientific Officer of the Allergy and Respiratory Unit of Pfizer. At Pfizer, Dr. Yeadon led the creation of one of the industry's leading allergy and respiratory portfolios, crafting a compelling strategy for the Allergy and Respiratory business, leveraging linkages between indications and exploiting inflammation ...

Corporate Headquarters

6400 Westwind Way
Crestwood, Kentucky 40014

United States

Phone: 502-241-4114
Fax: --

Board Members Memberships

There is no Board Members Memberships data available.

Education

PhD 1988
University of Surrey
BS
University of Surrey

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Apellis Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.